Media Room



Latest News Releases
Jun 6, 2017

Nektar Therapeutics (Nasdaq: NKTR) announced today that its corporate presentation will be webcast at the upcoming Jefferies 2017 Global Healthcare Conference in New York City on Wednesday, June...

Jun 5, 2017

Nektar Therapeutics (Nasdaq: NKTR) today announced that it presented new findings from two Phase 1 clinical studies of NKTR-214, Nektar's lead immuno-oncology candidate, a CD122-biased agonist, at...

May 22, 2017

Nektar Therapeutics (NASDAQ: NKTR) announced today that Takeda Pharmaceutical Company Limited (TSE: 4502) and Nektar have entered into a research collaboration to explore the combination of...

More »

Multimedia Libraries
Media Contacts
Dan Budwick
Pure Communications, Inc.

More »

Follow Us on LinkedIn
Follow Us on Twitter

print email
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide